Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia

J Thromb Haemost. 2018 Jul;16(7):1402-1412. doi: 10.1111/jth.14132. Epub 2018 Jun 5.

Abstract

Essentials The immunogenesis of Heparin-induced thrombocytopenia (HIT) is not well understood. Immunization to platelet factor 4 (PF4)-heparin occurs early in life, before any heparin exposure. PF4 and PF4-heparin complexes induce the proliferation of CD14+ cells. Reduced levels of regulatory cytokines contribute to immune dysregulation in HIT.

Summary: Background Heparin-induced thrombocytopenia (HIT) is an adverse reaction to heparin characterized by thrombocytopenia and thrombotic complications. HIT is caused by pathogenic antibodies that bind to complexes of platelet factor 4 (PF4) and heparin, leading to platelet activation and inducing a hypercoagulable state. Previous studies have shown immunity to PF4-heparin complexes occurs early in life, even before heparin exposure; however, the immunogenesis of HIT is not well characterized. Objectives To investigate cellular proliferation in response to PF4-heparin complexes in patients with HIT. Patients/Methods Peripheral blood mononuclear cells (PBMCs) from healthy controls (n = 30), postoperative cardiac surgery patients who had undergone cardiopulmonary bypass (CPB) (n = 17) and patients with confirmed HIT (n = 41) were cultured with PF4 and PF4-heparin complexes. Cellular proliferation was assessed by [3 H]thymidine uptake and 5-ethynyl-2'-deoxyuridine detection. Results and Conclusions PBMCs proliferated in the presence of PF4, and this was enhanced by the addition of heparin in all study groups. CPB and HIT patients showed significantly greater proliferative responses than healthy controls. PBMC proliferation was antigen-specific, depended on the presence of platelets, and only CD14+ cells were identified as proliferating cells. Culture supernatants were tested for the levels of regulatory cytokines, and both CPB and HIT patients produced significantly lower levels of interleukin-10 and transforming growth factor-β1 than healthy controls. These findings further demonstrate cellular immune sensitization to PF4-heparin complexes occurs before heparin exposure, and suggests immune dysregulation can contribute to HIT.

Keywords: CXCL4; cell proliferation; heparin; platelet factor 4; thrombocytopenia; thrombosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects*
  • Anticoagulants / immunology*
  • Case-Control Studies
  • Cell Proliferation*
  • Cells, Cultured
  • Female
  • Heparin / adverse effects*
  • Heparin / immunology*
  • Humans
  • Immunity, Cellular*
  • Interleukin-10 / blood
  • Interleukin-10 / immunology
  • Leukocytes, Mononuclear / immunology*
  • Leukocytes, Mononuclear / metabolism
  • Lipopolysaccharide Receptors / blood
  • Lipopolysaccharide Receptors / immunology
  • Male
  • Middle Aged
  • Platelet Factor 4 / blood
  • Platelet Factor 4 / immunology*
  • Thrombocytopenia / blood
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / immunology*
  • Transforming Growth Factor beta1 / blood
  • Transforming Growth Factor beta1 / immunology
  • Young Adult

Substances

  • Anticoagulants
  • CD14 protein, human
  • IL10 protein, human
  • Lipopolysaccharide Receptors
  • TGFB1 protein, human
  • Transforming Growth Factor beta1
  • Interleukin-10
  • Platelet Factor 4
  • Heparin

Grants and funding